Markets:

Overview

News

Currencies

International

Treasuries

Apyx Medical Corporation - Common Stock (NQ:APYX)

3.260 -0.010 (-0.31%)

Streaming Delayed Price Updated: 9:44 AM EST, Mar 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Apyx Medical Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Looking Into Apyx Medical's Return On Capital Employed ↗

September 07, 2022

According to Benzinga Pro data, during Q2, Apyx Medical (NASDAQ:APYX) posted sales of $10.29 million. Earnings were up 8.68%, but Apyx Medical still reported an overall loss of $5.45 million.

Via Benzinga

Apyx Medical Corporation to Participate in the Lake Street Best Ideas Growth Conference

September 06, 2022

From Apyx Medical Corporation

Via Business Wire

Short Interest Sector Focus: Healthcare Sector ↗

August 30, 2022

As of the close of business on Monday, 8/29, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

Apyx Medical Corporation Reports Second Quarter 2022 Financial Results and Updates Full Year 2022 Financial Outlook

August 11, 2022

From Apyx Medical Corporation

Via Business Wire

Apyx Medical's Renuvion Scores FDA Approval To Eliminate Sagging Neck ↗

July 18, 2022

Via Benzinga

Apyx Medical Posts Encouraging Data From Renuvion Device In Sagging Skin ↗

July 11, 2022

Via Benzinga

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗

August 15, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

Via Benzinga

Apyx Medical: Q2 Earnings Insights ↗

August 11, 2022

Apyx Medical (NASDAQ:APYX) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session ↗

August 12, 2022

Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year.

Via Benzinga

Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Reminds Apyx Medical Corporation (APYX) Investors of Class Action and Last Few Hours to Actively Participate

August 05, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medical Corporation (APYX)

August 04, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm

August 04, 2022

From The Schall Law Firm

Via Business Wire

APYX DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm

August 03, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm

August 03, 2022

From The Schall Law Firm

Via Business Wire

APYX FINAL DEADLINE ALERT: GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Apyx Medical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 5 Deadline in Securities Class Action - APYX

July 31, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

APYX DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Apyx Medical Corporation Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action – APYX

July 27, 2022

From Rosen Law Firm

Via Business Wire

Apyx Medical Corporation Releases Environmental, Social and Governance Data in New Tear Sheet

July 27, 2022

From Apyx Medical Corporation

Via Business Wire

APYX FINAL DEADLINE ALERT: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 5 Deadline in Securities Class Action - APYX

July 22, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Recap of Monday's Biotech Catalysts - End of the Day Summary ↗

July 18, 2022

Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...

Via Benzinga

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Improve Appearance of Lax (Loose) Skin

July 18, 2022

From Apyx Medical Corporation

Via Business Wire

APYX INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APYX

July 15, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Apyx Medical Corporation Announces Results of the U.S. IDE Clinical Study Evaluating the Use of Renuvion to Improve the Appearance of Lax Skin in the Neck and Submental Region

July 08, 2022

From Apyx Medical Corporation

Via Business Wire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - APYX

July 04, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022

June 30, 2022

From Apyx Medical Corporation

Via Business Wire

NASDAQ:APYX Investor Alert: Lawsuit Alleges Securities Laws Violations by Apyx Medical Corporation ↗

June 21, 2022

San Diego, CA -- (SBWIRE) -- 06/21/2022 -- An investor, who purchased NASDAQ:APYX shares, filed a lawsuit against Apyx Medical Corporation over alleged Federal Securities Laws violations.

Via SBWire

Apyx Medical Corporation Investor News: Robbins LLP is Investigating Apyx Medical Corporation (APYX) on Behalf of Shareholders

June 17, 2022

From Robbins LLP

Via Business Wire

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of APYX Medical Corporation (APYX) Investors and Encourages Investors to Contact the Firm Before August 5, 2022

June 17, 2022

From Kirby McInerney LLP

Via Business Wire

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medical Corporation (APYX)

June 13, 2022

From Law Offices of Howard G. Smith

Via Business Wire

APYX Shareholder News: Robbins LLP Reminds Investors of Class Action Against Apyx Medical Corporation (APYX)

June 10, 2022

From Robbins LLP

Via Business Wire

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.